FDA: Baxter, Salix should revise warning labels

03/23/2008 | Chicago Tribune (tiered subscription model) · Yahoo!

The FDA on Friday recommended new warnings for pediatric use of Suprane, Baxter International's inhaled anesthetic, and Colazal, Salix Pharmaceuticals Ltd.'s anti-inflammatory drug. The agency said Suprane should address cardiac arrest risk following three reported cases among children, while Colazal should have warnings on heart and lung risks that other drugs in the same class carry.

View Full Article in:

Chicago Tribune (tiered subscription model) · Yahoo!

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations
Market Intelligence Manager
Olympus Corporation of the Americas
Southborough, MA